AMR research: a perspective from personal experience

Vijay Kothari

doi:10.33393/dti.2022.2545

AMR research: a perspective from personal experience

Authors

Vijay Kothari Institute of Science, Nirma University, Ahmedabad - India https://orcid.org/0000-0003-1035-7217

DOI:

https://doi.org/10.33393/dti.2022.2545

Keywords:

AMR, Antimicrobial resistence

Abstract

Downloads

Download data is not yet available.

References

Kothari V. Adopting an Anti-virulence (anti-pathogenicity) Approach for Dealing with the Problem of Antimicrobial Resistance. Recent patents on Biotechnology. 2019; 13:252-255. http://dx.doi.org/10.2174/187220831304191025092737 DOI: https://doi.org/10.2174/187220831304191025092737

Theuretzbacher U, Outterson K, Engel A, Karlén A. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 2020 May;18(5):275-285. https://doi.org/10.1038/s41579-019-0288-0 PMID 31745331 DOI: https://doi.org/10.1038/s41579-019-0288-0

Kothari V. Validation of Traditional Medicinal Practices Through Modern Scientific Approach: A Case for Reconsideration. Current Pharmacogenomics and Personalized Medicine. 2020;17:11-13. http://dx.doi.org/10.2174/1875692118666191223155350 DOI: https://doi.org/10.2174/1875692118666191223155350

Kothari V. Eukaryotic microorganisms in microbiology syllabi: better representation needed. Journal of Applied Biotechnology & Bioengineering. 2016; 1:42. https://doi.org/10.15406/jabb.2016.01.00007 DOI: https://doi.org/10.15406/jabb.2016.01.00007

Downloads

Published

2022-12-23

How to Cite

Kothari, V. (2022). AMR research: a perspective from personal experience. Drug Target Insights, 16(1), 69–70. https://doi.org/10.33393/dti.2022.2545

Download Citation

Issue

Vol. 16 No. 1 (2022): January-December 2022

Section

Focus on Antimicrobial Resistance (AMR)

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors contributing to Drug Target Insights agree to publish their articles under the Creative Common Attribution Non Commercial 4.0 (CC-BY-NC 4.0) license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.